Stock Track | Progyny Plummets 11.21% Intraday on Disappointing Guidance, Client Loss and Slowing Growth

Stock Track02-27 22:36

Progyny's (PGNY) stock plummeted 11.21% during intraday trading on Friday, following a significant decline in pre-market activity.

The sharp drop comes after the company issued financial guidance that fell short of analyst expectations. Progyny's outlook for the first quarter of 2026 and its adjusted earnings per share guidance for the full year 2026 were both below market expectations, triggering negative investor sentiment.

Further pressure stemmed from the company's projection of slower revenue growth for fiscal year 2026, estimated between 5.1% and 9%, which represents a deceleration from the 10% growth achieved in 2025. The first-quarter 2026 revenue growth guidance of just 2.5% was particularly disappointing to analysts. The company also confirmed the loss of a large client that did not renew its contract, and reported a 1.1% revenue decline in its pharmacy benefit services segment during the latest quarter.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment